- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Relapsed/Refractory Locally Advanced or Metastatic Breast Cancer and Triple Negative Breast Cancer in Canada
Total 307 results
-
Dr. Christopher MuellerCanadian Institutes of Health Research (CIHR); Queen's UniversityRecruitingMetastatic Breast CancerCanada
-
Canadian Cancer Trials GroupAstraZenecaCompletedMetastatic Breast CancerCanada
-
Ozmosis Research Inc.Breast Cancer Research FoundationCompletedMetastatic Breast CancerCanada
-
MedImmune LLCCompletedHormone-sensitive, HER-2 Negative Metastatic Breast CancerSpain, United States, Belgium, France, United Kingdom, Canada, Israel, Germany, Hungary, Poland, Bahamas
-
AstraZenecaNot yet recruiting
-
University Health Network, TorontoTerminatedMetastatic Breast CancerCanada
-
Mundipharma Research LimitedCompletedSoft Tissue Sarcoma | Ovarian Cancer | Endometrial Cancer | Small-cell Lung Cancer | Triple-negative Breast CancerUnited States, Canada
-
Sunnybrook Health Sciences CentreCentre hospitalier de l'Université de Montréal (CHUM); Exactis Innovation; Princess...RecruitingOvarian Cancer | Triple Negative Breast Cancer | High Grade Serous CarcinomaCanada
-
University Health Network, TorontoMerck Sharp & Dohme LLCActive, not recruitingAdvanced Solid Tumors | Triple Negative Breast Cancer | Epithelial Ovarian Cancer | Malignant Melanoma | Squamous Cell Cancer of Head and NeckCanada
-
University Health Network, TorontoCanadian Breast Cancer FoundationCompletedMetastatic Breast Cancer With Bone InvolvementCanada
-
TheratechnologiesPPD; Syneos Health; Windtree Therapeutics; Innovaderm Research Inc.; Altasciences...RecruitingSolid Tumor | Prostate Cancer | Endometrial Cancer | Epithelial Ovarian Cancer | Small-cell Lung Cancer | Thyroid Cancer | Cutaneous Melanoma | TNBC - Triple-Negative Breast Cancer | Hormone Receptor-positive Breast Cancer | SORT1+ CancersUnited States, Canada
-
Zetagen Therapeutics, IncRecruitingMetastatic Breast Cancer in the SpineCanada
-
National Cancer Institute (NCI)Active, not recruitingInvasive Breast Carcinoma | Triple-Negative Breast Carcinoma | Stage I Breast Cancer AJCC v7 | Stage II Breast Cancer AJCC v6 and v7 | Stage III Breast Cancer AJCC v7 | Stage 0 Breast Cancer AJCC v6 and v7United States, Canada, Puerto Rico
-
University of PisaCompleted
-
Canadian Cancer Trials GroupOncolytics BiotechCompletedMetastatic Breast CancerCanada
-
University of PisaUnknown
-
Ontario Clinical Oncology Group (OCOG)Canadian Breast Cancer Research Alliance; Ontario Cancer Research NetworkCompletedMetastatic Breast Cancer | Recurrent Breast CancerCanada
-
Puma Biotechnology, Inc.CompletedBreast Neoplasms | Advanced Breast Cancer | Advanced Malignant Solid TumorsUnited States, Belgium, China, Hong Kong, Canada, Korea, Republic of, India, Poland, Ukraine
-
Jewish General HospitalQuebec Breast Cancer FoundationRecruitingSentinel Lymph Node | Breast Cancer Female | Lymph Node Metastases | Early-stage Breast Cancer | Axillary MetastasesCanada
-
NSABP Foundation IncEisai Inc.CompletedBreast Cancer | HER2-negative Breast CancerUnited States, Canada
-
CelgeneTerminated
-
Eisai Inc.Approved for marketingMetastatic Breast CancerCanada, Belgium, France
-
PeriPharmPfizerCompleted
-
Merrimack PharmaceuticalsCompletedHer2 Negative Breast Cancer PatientsUnited States, Spain, Canada, Germany, Russian Federation
-
Ontario Clinical Oncology Group (OCOG)AstraZenecaCompleted
-
Janssen Diagnostics, LLCCompletedMetastatic Breast CancerUnited States, Canada
-
PfizerTerminatedAdvanced Breast CancerUnited States, Hungary, Spain, Belgium, China, Hong Kong, Australia, Poland, Canada, India, South Africa
-
Genentech, Inc.UnknownMetastatic Breast CancerAustralia, Spain, Greece, Mexico, Russian Federation, United States, Singapore, Canada, Peru, Taiwan, Korea, Republic of, Philippines, Netherlands, United Kingdom, France, Brazil, Ukraine, Sweden, Guatemala, Panama, Norway, Uruguay
-
Athenex, Inc.CompletedMetastatic Breast CancerArgentina, Chile, Colombia, Dominican Republic, Ecuador, El Salvador, Guatemala, Honduras, Panama, Peru
-
Novartis PharmaceuticalsActive, not recruitingMelanoma | Pancreatic Cancer | Triple Negative Breast Cancer | Head and Neck Squamous Cell Cancer | Esophageal Squamous Cell Cancer | BRAF Mutant Colorectal Cancer | Cervical Squamous Cell Cancer | Lung Squamous Cell CancerCanada, Italy, Spain, Germany, Netherlands, United States, France
-
SOLTI Breast Cancer Research GroupCompletedMetastatic Breast CancerSpain
-
Ontario Clinical Oncology Group (OCOG)Cancer Care OntarioCompletedStage III Breast Cancer (T0N2, T1N2, T2N2, T3N1, 2 or T4) | Stage IIb Breast Cancer (T3N0)Canada
-
AstraZenecaDaiichi Sankyo Co., Ltd.; Daiichi Sankyo Company, LimitedActive, not recruitingMetastatic Breast CancerBelgium, United States, Taiwan, Korea, Republic of, Brazil, Russian Federation, Canada, Australia, France, Mexico
-
Institut Investigacio Sanitaria Pere VirgiliInstitut Català d'Oncologia; Hospital Universitario Ramon y Cajal; Hospital Arnau... and other collaboratorsRecruitingMetastatic Colorectal Cancer | Metastatic Lung Cancer | Metastatic Breast Cancer | Metastasis | Metastatic Prostate CancerSpain
-
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo CompanyRecruitingMetastatic Breast Cancer | Unresectable Breast Cancer | HER2-low Expressing Breast CancerAustria, Belgium, Italy, Spain, France, Switzerland, Denmark, Norway, Sweden
-
Spanish Breast Cancer Research GroupNovartis Pharmaceuticals; ETOP IBCSG Partners Foundation; Breast International...Active, not recruitingAdvanced Breast CancerSpain, Netherlands, France, Italy, Austria, Switzerland
-
Hoffmann-La RocheRoche Pharma AGCompletedMetastatic Breast CancerItaly, Spain, Canada, United States, Belgium, France, Germany
-
PfizerNo longer available
-
MacroGenicsCompletedHER-2 Positive Breast Cancer | Metastatic NeoplasmUnited States, Spain, Italy, Canada, Israel, Belgium, Germany, Czechia, Austria, Korea, Republic of, Denmark, United Kingdom, Portugal, France, Poland, Netherlands, Finland, Puerto Rico
-
Novartis PharmaceuticalsCompletedMetastatic Breast CancerUnited States, Canada, Finland, France, Italy, Spain, Taiwan, United Kingdom
-
Novartis PharmaceuticalsCompletedHR+ HER2- Men, Pre/Postmenopausal Advanced Breast CancerCanada
-
Eli Lilly and CompanyAvailableMetastatic Breast CancerAustralia, Canada, Egypt, India, Italy, Korea, Republic of, Malaysia, Singapore, South Africa, Spain, Switzerland, Taiwan, Thailand, United Kingdom
-
Novartis PharmaceuticalsCompletedAdvanced Breast CancerBelgium, Italy, Czechia, Hungary, Canada, Netherlands, Germany, Singapore, Australia, Denmark, Poland, Switzerland, Korea, Republic of, Spain, Thailand, Lebanon, Austria, Bulgaria, Russian Federation, Norway, Jordan, United States, ... and more
-
Byondis B.V.CompletedMetastatic Breast CancerFrance, United States, United Kingdom, Belgium, Spain, Italy, Singapore, Denmark, Sweden, Canada, Netherlands
-
Sermonix Pharmaceuticals Inc.RecruitingMetastatic Breast CancerUnited States, France, Belgium, Spain, Israel, Taiwan, United Kingdom, Korea, Republic of, Italy, Australia, Germany, Canada, Czechia, Hungary, Poland, Romania, Singapore, Turkey
-
Elevation OncologyTerminatedMetastatic Breast CancerGermany, Spain, United States, Austria, Belgium, Canada
-
PfizerCompletedMetastatic Breast CancerSpain, Belgium, Sweden, United Kingdom, Austria, Germany, Switzerland
-
Hoffmann-La RocheCompletedMetastatic Breast CancerUnited States, Korea, Republic of, United Kingdom, Germany, Spain, Taiwan, Australia, Canada, Italy
-
SOLTI Breast Cancer Research GroupNovartis; Alliance Foundation Trials, LLC.RecruitingMetastatic Breast CancerUnited States, Spain, Portugal
-
Gilead SciencesCompletedMetastatic Breast CancerUnited States, Spain, United Kingdom, Italy, Canada, France, Germany, Belgium, Netherlands